APGE — APOGEE THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in APOGEE THERAPEUTICS INC (APGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.19% (2024 Q3)
Avg. % of fund
0.04%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 110,500 +105,700 +2202.1% 0.03% $4.4M $39.73
2025 Q3 REDUCED 4,800 -52,800 -91.7% 0.00% $191K $39.73
2025 Q2 ADDED 57,600 +47,571 +474.3% 0.03% $2.5M $43.43
2025 Q2 REDUCED 10,029 -84,971 -89.4% 0.00% $436K $43.43
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APGE price (monthly, adj. close)

Other funds also holding APGE

As of 2025 Q4 — sorted by position size

VR Adviser, LLC 3Y 31.67% Remedium Capital Partners, LLC 25.88% Fairmount Funds Management LLC 3Y 11.77% GREAT POINT PARTNERS LLC 3Y 7Y 9.15% Affinity Asset Advisors, LLC 3Y 5.31% First Turn Management, LLC 4.1% Opaleye Management Inc. 3Y 7Y 3.87% Novo Holdings A/S 3Y 7Y 3.34% PERCEPTIVE ADVISORS LLC 3Y 7Y 3.14% Paradigm Biocapital Advisors LP 3Y 2.16%
← Back to Caption Management, LLC Holdings